CT1812 not checked

Cognition Therapeutics

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
1 active
9 in total
Targets
 

What this is

How it works
How it works isn't classified yet
Tested for
Early Alzheimer's Disease
Main trialPhase 2
“This is a multicenter randomized, double-blind, placebo-controlled Phase 2 study designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's disease.”In the company’s words, NCT05531656 on ClinicalTrials.gov
Other names
zervimesine

Other drugs for Early Alzheimer's Disease

All 90 drugs for Early Alzheimer's Disease

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials9

TrialPhaseCompletesWhat it tests
Phase 2Active, not recruiting 31 May 2027 A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease
Phase 2Completed 26 Apr 2023 Pilot Clinical Study of CT1812 in Mild to Moderate Alzheimer's Disease Using EEG
Phase 2Completed 29 May 2024 A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.
Phase 2Completed 25 Nov 2024 Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies
Phase 2Terminated 4 Mar 2025 Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).
Phase 1/2Completed 16 Oct 2020 Effect of CT1812 Treatment on Brain Synaptic Density
Phase 1Completed 6 Feb 2019 Study to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's Disease
Phase 1Completed 17 Jan 2022 Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of CT1812 in Healthy Adult Male Subjects
Phase 1Completed 1 Jun 2022 Study to Assess the Pharmacokinetics of CT1812 in Older Healthy Volunteers
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow CT1812

Following is part of Solo: you see every change to CT1812 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in